SureTrader SureTrader
Home > Boards > US OTC > Cannabis >

Digipath Inc (DIGP)

Add DIGP Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 10/18/2016 11:37:29 AM - Followers: 48 - Board type: Free - Posts Today: 0
For information see:


DigiPath’s team brings over 60 years combined expertise in pioneering digital pathology, implementing over 750 installations at academic medical centers, reference laboratories, biopharma organizations, and life science research institutions worldwide.



PathScope™ is a whole slide imaging system. PathScope™ provides high quality images in an open file format, which works with third party software packages. PathScope™ objectives can be configured with either 2, 4, 10, 20, 40, or 60x. Stage capacity options are 2, 4, or 200 slide trays.

Path Scope


PathLive™ is an affordable real time telepathology system. PathLive provides high quality images in a real time fashion and allows the remote user to remotely control objective magnifications, X & Y axis stage location, and Z axis focus plane. PathLive™ objectives can be configured with 4, 10, 20, and 40x objectives. Stage capacity is 2 slides.



Since June 2011, DigiPath has provided PathReview™, as a web viewer and image server management system for whole digital slide images. PathReview™ supports files produced by DigiPath's PathScope™, and 5 other digital pathology systems. PathReview™ includes standard annotation, measurement, and conferencing capabilities. PathReview™ works with most common web browsers, without any plug-ins required.


Since June 2011, DigiPath has provided PathConsult™, as end to end digital pathology solution to support remote consultation, 2nd opinions, and reporting capabilities. PathConsult™ provides workflows specifically for histotechnicians, pathologists, and administrators. DigiPath's PathScope™, and 5 leading digital pathology systems. PathConsults™ includes standard annotation, measurement, and conferencing capabilities. PathConsult™ works with most common web browsers, without any plug-ins required.



DigiPath’s team built telecom networks which supported over 35,000 locations throughout the country. DigiPath brings this IT experience to PathCloud™, the first and only telecom network optimized for digital pathology. PathCloud™ is an affordable, innovative, and reliable digital pathology solution networked engineered and optimized for highest digital pathology performance and reliability. PathCloud™ removes all your data storage and connectivity concerns..


PathTrade™ is the exchange initiative that provides affordable and innovative digital pathology solutions, while also providing means for underserved communities to access pathology educational and medical experts throughout the world. PathTrade™ provides existing telepathology users an affordable means to upgrade discontinued telepathology systems with a DigiPath solution.

DigiPath will provide $500 to $5,000 as a trade-in credit for upgrading to PathScope and/or PathLive. Additionally, DigiPath will refurbish the used system, and deploy system without any additional fees, in communities in need of pathology educational and medical experts. DigiPath has identified many underserved communities in Africa, India, Middle East, Southeast Asia, Caribbean, and South America, for installation in 2012.


PathStore™ is a web based e-commerce vehicle for professional serives (consultations, 2nd opinions, & quality assurance) and third party software developers to market, sell, and implement their digital pathology solutions to PathScope™ users. PathStore™ includes the ability to place third party applications on the PathScope™ desktop, or in the connected PathCloud™ network. PathStore™ will be released worldwide in 2014.


PathGuarentee™ is the digital pathology industry’s first MONEY BACK GUARANTEE program. Email for more details.

DigiPath develops and sells the affordable, innovative, and reliable digital pathology solutions for 2 nd opinion, consultation, tumor board, archiving, and educational purposes for improved workflow, analysis and data mining in support of pathology in academic medical centers, reference laboratories, biopharma organizations, and life science research institutions. Our digital pathology image-based information environment enabled by computer technology that allows for the management of information generated from a digital slide. Digital pathology is enabled in part by virtual microscopy, which is the practice of converting glass slides into digital slides that can be viewed, managed, and analyzed. Our digital pathology products, PathScope™, PathCloud™, PathReview™, and PathConsult™ provide a digital platform to share and store archive tissue images.

Digital Pathology Products Summary

DigiPath's digital pathology products are digital pathology solutions which employ the optical components of a standard microscope, robotic automated slide handling capabilities combined with proprietary imaging and communication software to capture high magnification images in digital format. These devices are comprised of both hardware and software.

DigiPath's digital pathology products, marketed under the names PathScope, PathCloud, PathReview, and PathConsult are used in hospital, educational pharmaceutical and research environments. Digital pathology solutions also include names of whole slide imaging and telepathology.

PathScope™ hardware

DigiPath’s PathScope is affordable, innovative, and reliable digital pathology solution. Depending on configuration, the pricing ranges from $25,000 to $75,000 capital purchase option. The options include capacity (1, 2, 3, 20, 30), objective (2.5x, 5x, 10x, 20x, 40x, 60x, 100x), barcode, and file format (JPEG, JP2k, TIFF). The reliability is based on 14 day validation period option, HIPPA, and 21CFR11 compliance.

PathCloud™ service

DigiPath's PathCloud is an affordable digital pathology solution networked engineered and optimized for digital pathology performance and reliability. PathCloud includes a USA national backbone network with 8 points of presence, 1000 TB storage, and 100M bandwidth, optimized for digital pathology. The reliability is based on PathCloud’s service level agreement which includes; 100% availability, 100% packet delivery, sub 200 milliseconds latency, and sub 1 second viewing time.

PathReview™ and PathConsult TM software

DigiPath's PathReview provides a scanner agnostic viewer and image server to review images via third party browsers, including Chrome, Internet Explorer, Firefox, and Safari. PathConsult has the features of PathReview with capability of doing a report and searchable database.

Advisory service(s)

DigiPath’s advisors bring over 60 years combined expertise in pioneering digital pathology, implementing over 500 installations at academic medical centers, reference laboratories, biopharma organizations, and life science research institutions worldwide. DigiPath provides advisory services for clients involved with digital pathology. Our current services range the full breadth of management operations for marketing, product development, sales outreach, operations, and customer support services. Our current clients seek our assistance in rolling out affordable, innovative, and reliable digital pathology solutions. Our potential clients include manufacturer (hardware and software), distribution and service firms, laboratories (reference, hospital owned, independent), private pathology practices (associated with hospitals), and centers of excellence.

Product Distribution

The Company sells its products either directly to end users, through exclusive distributors, non-exclusive distributors, and OEM (third party brands) depending on the application and the geographical location of the customer. Generally, qualified distributors and OEM are already in the business of selling bright field microscopes, equipment for medical analysis, or other laboratory equipment. Under the terms of the Company’s standard distribution agreements, distributors and OEM partners are assigned exclusive or non-exclusive territories or markets and, in turn, commit to purchasing a minimum amount of DigiPath products on either a quarterly or monthly basis.

Competitive Conditions

The digital pathology market is highly competitive, and many of our competitors have greater resources and better name recognition than we do. We primarily compete on affordability, innovation, and reliability. Our competitors in the digital pathology market include, Aperio, Apollo Telemedicine, D-Metrix, Hamamatsu, Nikon, Olympus, Carl Zeiss, OMNYX (owned by GE and UPMC), Leica (owned by Danaher), Phillips, Sakura, Roche, Claro, and MikroScan.

For advisory services, there are other firms providing such advisory services in the digital pathology space. There is currently an abundant need for such advisory services and we have not seen this as inhibiting our ability to garner new clients. Additionally, on larger engagements, we currently work with other advisory service firms which may be deemed as competitors. Some firms which we identified as clients may provide competitive services.


Digital pathology is the process of creating virtual slides by building digital images of physical tissue samples. Digital pathology allows drug developers, pathologists and researchers to be view tissue images through a computer or over a standard Internet connection and can be stored for later interpretation and archiving; and data mining in support of computer aided quantitative histopathology. The digital pathology markets can be categorized by type of tissue (human or animal) and use (clinical or research).

Digital pathology may improve patient care with a faster diagnosis time, more accurate diagnosis, more reproducible diagnosis, and probable lower medical costs. The improvement areas are a result of digital pathology means to provide faster turnaround time, faster access to sub-specialist, fast access to 2nd opinion, and more cost effective medical diagnosis’s.

Digital pathology is rapidly gaining momentum by reduce laboratory expenses, improve operational efficiency, enhance productivity, and improve treatment decisions and patient care. It is used worldwide in drug development, reference lab, hospital, and academic medical center settings. Applications include education, research, image analysis, archival and retrieval, laboratory information system (“LIS”) integration, secondary consultations, and virtual slide sharing. Today, education and training is the most common use for labs using digital pathology. The biggest barrier to more clinical use is the cost of scanning digital slides, which does not eliminate the need to first prepare glass slides.

Human Pathology

We estimate a total of 16,500 pathologists in the United States, with approximately two-thirds or 11,000 practicing anatomic pathology. These pathologists generally practice within one or more market segments, including hospital based pathology labs, integrated health systems, and commercial and academic research.

Pathologists focusing on human disease study the origin, course and indicators of disease. Pathology divides into clinical pathology the analysis of fluids such as urine and blood and DigiPath's market, anatomic pathology the analysis of tissue. Clinical pathology market is dominated by large national laboratories that use large-scale automation and is generally a high volume, low margin business. The technology for the automation of anatomic pathology has lagged that of clinical pathology. As a result, anatomic pathology remains a less consolidated and higher margin industry.

Animal (Veterinary) Pathology

Animal pathology includes testing in research and clinical treatment of both pets and livestock. Animal pathology for treatment is mainly conducted by labs providing services to veterinary practices. The majority of animal pathology is conducted by pharmaceutical and biotechnology companies for drug development.

The dynamics of veterinary pathology for treatment resemble human clinical pathology. Veterinary pathologists seek to improve access to clinical specialists: and aim to improve management and archiving of data workflow and tissue analysis.

The key market segments in animal pathology are pharmaceutical toxicology groups, academic and government research, contract research organizations (“CROs”), and biotechnology firms.

Digital Pathology Applications

Digital pathology products share common uses in both human and animal pathology, including consultation, communication and collaboration, education and publication, archiving and management, workflow, and analysis, as described below.

Consultation, Communication and Collaboration

Pathologists frequently consult with other pathologists and specialists in carrying out their daily work. There are often delays in consulting due to the transportation of slides or having to travel to distant locations in order to meet face-to-face. DigiPath's products allow sharing of images real time, eliminating the need for slide transportation or travel. Pathologists and specialists are able to simultaneously view and manipulate the slides and provide consultation in real-time. In addition, communication is improved as multiple pathologists and specialists can view and manipulate the same slide simultaneously.
- 4 -
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#420   News out, they're attending a conference for cannabis Mike1019 10/18/16 11:37:29 AM
#419   starts some here...low o/s why not DRspin 10/18/16 10:17:57 AM
#418   And spreads just really widened...LOL Mike1019 10/06/16 09:59:11 AM
#417   News out today, see below. Also nice Mike1019 10/06/16 09:43:11 AM
#416   yeah I feel the same...I know yall know oatsuzn 10/04/16 03:26:32 PM
#415   Agreed - that's why I'm not taking a senor_c 10/04/16 02:30:11 PM
#414   .03 spread between ASK and BID will continue Luckydog83 10/04/16 01:36:15 PM
#413   PZOO up 600%, DIPG, zilch... Luckydog83 10/04/16 01:13:56 PM
#412   Recently bought into this one, low float is Mike1019 10/03/16 09:06:20 PM
#411   Perhaps - not sure senor_c 10/03/16 07:36:59 PM
#410   how come this is not running at all. all4weed 10/03/16 05:14:38 PM
#409   Thanks for the thoughts. I'm with you on senor_c 09/25/16 08:54:12 PM
#408   Si senor, that's what I'm talking about-- although, Bullsonmonday 09/25/16 08:40:32 PM
#407   Oh - I see now - cash raised senor_c 09/25/16 05:27:23 PM
#406   substantial amount of cash senor_c 09/25/16 05:21:49 PM
#405   Depends. Signal Bay has more labs but the Bullsonmonday 09/25/16 01:36:22 AM
#404   Check out SGBY, a better play in the sector. ford7319 09/24/16 10:25:36 PM
#403   Float considered, DIGP is very cheap right now-- Bullsonmonday 09/20/16 09:16:44 PM
#402   DIGP bullish 0.23 stocktrademan 09/09/16 01:35:11 PM
#401   Don't miss this low floater poised to kick CannabidiolHead 08/22/16 07:35:19 PM
#400   Can't find anything wrong with this company low CannabidiolHead 08/18/16 10:11:23 AM
#399   MJ testing has a huge upside in the Dissius 08/17/16 08:33:44 PM
#398   According to GreenWave Advisors, a comprehensive independent research CannabidiolHead 08/16/16 07:30:56 PM
#397   Get it while it's low... CannabidiolHead 08/16/16 07:08:21 PM
#396   This is a sleeper...lets pump this thing. CannabidiolHead 08/16/16 07:07:26 PM
#395   NEW YORK, NY--(Marketwired - Aug 10, 2016) - CannabidiolHead 08/16/16 07:05:21 PM
#394   Arizona based Digipath is slowing gaining revenues....20,000,000 outstanding CannabidiolHead 08/16/16 07:01:51 PM
#393   Arizona Marijuana Legalization CannabidiolHead 08/16/16 07:00:07 PM
#392   Digipath revenues were generated by our cannabis testing CannabidiolHead 08/16/16 06:54:51 PM
#391   I wish I knew??? Anyone know? TwoScoops 07/28/16 02:45:48 PM
#390   What happen today. willlbone 07/28/16 01:30:05 PM
#389   $DIGP (DigiPath) Labs Sign Cannabis Testing Agreement with UptickSocial 07/26/16 05:57:26 PM
#388 VSAStory 06/30/16 10:04:50 AM
#387   DIGP and SGBY both cornering the market IMO SGBY VSAStory 06/29/16 12:17:44 PM
#386   comparing DIGP AND SAKL.. i would much rather villawest 05/18/16 12:40:52 AM
#385   Glad I held here! 420 should give DIGP jjh573 04/18/16 01:29:05 PM
#384   $DIGP: good to go. it will run like the Camelot 04/12/16 12:04:29 PM
#383   $DIGP: Should be able to hit $1 in a Camelot 04/06/16 02:50:08 PM
#382   Actually, no one interested in this mj play... Luckydog83 04/05/16 11:49:43 PM
#381   $DIGP: very strong buy at these levels. Camelot 04/04/16 01:14:06 AM
#380   Conversion price at $0.30 kicks in for latest 8K... Luckydog83 04/03/16 09:48:25 AM
#379   Agreed! Major moves coming for DIGP. Enjoy the jjh573 04/03/16 08:23:45 AM
#378   we could see 30 cents to 35 cents Camelot 04/02/16 11:46:41 PM
#377   DIGP looking good! Volume is increasing with price. jjh573 04/02/16 05:01:38 PM
#376   $DIGP: Excellent volume again. Camelot 04/01/16 03:53:57 PM
#375   next destination: Camelot 04/01/16 07:25:35 AM
#374   $DIGP #10 on Top 10 OTC Advancers today! Airdawg Investments 03/31/16 10:44:52 PM
#373   $DIGP is light years ahead of PZOO. Camelot 03/31/16 06:17:12 PM
#372   my brother got in on digp but he villawest 03/31/16 04:26:13 PM
#371   best in class and first to market advantage Camelot 03/31/16 09:40:55 AM